RaySearch Laboratories AB (publ) (RAY-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.60 Million ≈ $-1.25 Million USD) by net assets (Skr919.30 Million ≈ $98.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
RaySearch Laboratories AB (publ) - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how RaySearch Laboratories AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read RaySearch Laboratories AB (publ) balance sheet liabilities for a breakdown of total debt and financial obligations.
RaySearch Laboratories AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RaySearch Laboratories AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
S.J.S. Enterprises Limited
NSE:SJS
|
0.028x |
|
Shenzhen Asiantime International Construction Co Ltd
SHE:002811
|
0.071x |
|
Dap Gayrimenkul Gelistirme AS
IS:DAPGM
|
0.038x |
|
Zhongjin Irradiation Incorporated Company
SHE:300962
|
0.046x |
|
Zhongrui Co Ltd
SHE:301587
|
0.017x |
|
Shanghai Metersbonwe Fashion&Accessories Co Ltd
SHE:002269
|
-0.591x |
|
Daewoong
KO:003090
|
0.052x |
|
Anhui Zhonghuan Environmental Protection Technology Co Ltd
SHE:300692
|
0.028x |
Annual Cash Flow Conversion Efficiency for RaySearch Laboratories AB (publ) (2003–2024)
The table below shows the annual cash flow conversion efficiency of RaySearch Laboratories AB (publ) from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see RAY-B market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr876.71 Million ≈ $94.35 Million |
Skr485.23 Million ≈ $52.22 Million |
0.553x | -10.75% |
| 2023-12-31 | Skr735.23 Million ≈ $79.12 Million |
Skr455.93 Million ≈ $49.07 Million |
0.620x | +14.22% |
| 2022-12-31 | Skr657.16 Million ≈ $70.72 Million |
Skr356.78 Million ≈ $38.39 Million |
0.543x | +48.01% |
| 2021-12-31 | Skr649.28 Million ≈ $69.87 Million |
Skr238.16 Million ≈ $25.63 Million |
0.367x | -23.17% |
| 2020-12-31 | Skr694.35 Million ≈ $74.72 Million |
Skr331.51 Million ≈ $35.68 Million |
0.477x | +5.21% |
| 2019-12-31 | Skr705.47 Million ≈ $75.92 Million |
Skr320.14 Million ≈ $34.45 Million |
0.454x | +67.17% |
| 2018-12-31 | Skr657.45 Million ≈ $70.75 Million |
Skr178.47 Million ≈ $19.21 Million |
0.271x | +6.84% |
| 2017-12-31 | Skr580.42 Million ≈ $62.46 Million |
Skr147.48 Million ≈ $15.87 Million |
0.254x | -3.24% |
| 2016-12-31 | Skr460.19 Million ≈ $49.52 Million |
Skr120.85 Million ≈ $13.01 Million |
0.263x | -24.70% |
| 2015-12-31 | Skr319.52 Million ≈ $34.39 Million |
Skr111.43 Million ≈ $11.99 Million |
0.349x | +74.49% |
| 2014-12-31 | Skr251.55 Million ≈ $27.07 Million |
Skr50.27 Million ≈ $5.41 Million |
0.200x | +25.60% |
| 2013-12-31 | Skr196.60 Million ≈ $21.16 Million |
Skr31.28 Million ≈ $3.37 Million |
0.159x | -60.42% |
| 2012-12-31 | Skr217.55 Million ≈ $23.41 Million |
Skr87.45 Million ≈ $9.41 Million |
0.402x | +133.57% |
| 2011-12-31 | Skr196.70 Million ≈ $21.17 Million |
Skr33.85 Million ≈ $3.64 Million |
0.172x | -46.06% |
| 2010-12-31 | Skr196.76 Million ≈ $21.17 Million |
Skr62.78 Million ≈ $6.76 Million |
0.319x | +19.87% |
| 2009-12-31 | Skr184.86 Million ≈ $19.89 Million |
Skr49.21 Million ≈ $5.30 Million |
0.266x | +53.75% |
| 2008-12-31 | Skr150.44 Million ≈ $16.19 Million |
Skr26.05 Million ≈ $2.80 Million |
0.173x | -36.96% |
| 2007-12-31 | Skr137.85 Million ≈ $14.83 Million |
Skr37.86 Million ≈ $4.07 Million |
0.275x | +7.77% |
| 2006-12-31 | Skr118.07 Million ≈ $12.71 Million |
Skr30.09 Million ≈ $3.24 Million |
0.255x | -49.60% |
| 2005-12-31 | Skr81.85 Million ≈ $8.81 Million |
Skr41.39 Million ≈ $4.45 Million |
0.506x | +28.56% |
| 2004-12-31 | Skr32.72 Million ≈ $3.52 Million |
Skr12.87 Million ≈ $1.39 Million |
0.393x | +11.83% |
| 2003-12-31 | Skr19.82 Million ≈ $2.13 Million |
Skr6.97 Million ≈ $750.30K |
0.352x | -- |
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a tre… Read more